Searched for
SUN PHARMA DIVIDEND
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...- Eicher Motors Q4 Results: Cons profit grows 12% YoY to Rs 1,520 crore, revenue jumps 16%Eicher Motors, the maker of Royal Enfield, posted a 12% rise in net profit for the March quarter of FY26. The company's revenue also saw a ...
- Sun Pharma Q4 Results: Cons profit rises 26% YoY to Rs 2,714 crore; board approves Rs 5/share dividendSun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...
- Stocks in news: ITC, LIC, Sun Pharma, Maruti Suzuki, Fino Payments BankBenchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Sun Pharma shares rally 4% as Q3 profit surges 16% YoY; co announces interim dividendSun Pharma shares rose sharply on Sunday after the company reported a 16% YoY rise in Q3 net profit to Rs 3,369 crore, supported by strong ...
- Sun Pharma Q3 profit jumps 16% YoY as branded and innovative businesses drive growthSun Pharma announced strong third quarter results. Sales rose 15% to Rs 15,469 crore and net profit climbed 16% to Rs 3,368 crore. Growth w...
- Sun Pharma Q3 Results: Cons PAT jumps 16% YoY to Rs 3,369 crore; Rs 11/share interim dividend declaredSun Pharma posted a strong Q3FY26 performance with net profit up 16% and revenue rising 13%. EBITDA surged 23% as margins expanded to 31.9%...
- Sun Pharma Q4 Results: Cons PAT falls 19% YoY to Rs 2,154 crore; Rs 5.5/share dividend announcedSun Pharma reported a 19% YoY drop in Q4FY25 net profit to Rs 2,154 crore, while revenue rose 8% to Rs 12,959 crore. Final dividend set at ...
- Sun Pharma announces Rs 10.50/share interim dividend, sets Feb 6 as record dateThe company set February 6, 2025, as the record date for the dividend, payable by February 20, 2025. The company announced the dividend alo...
- Sun's shining bright in India, rising across the world, tooThe revenues for the quarter grew nearly 10% while the net profit rose 16.5%. Both the domestic and US markets reported double-digit growth...
- TaMo, Adani Ports among stocks that will trade ex-dividend this weekAccording to StockEdge data, Tata Motors, Sun Pharma, DLF, Indian Oil Corporation, UltraTech Cement, and Adani Ports will trade ex-dividend...
- 2 Nifty stocks to trade ex-dividend this weekCoal India has announced an interim dividend of Rs 5.25 for the current fiscal, along with its third quarter financial results, and will go...
- Sun Pharma reports 13.6% drop in Q4 net profit at Rs 1,224 croreThe drug maker had reported a profit of Rs 1,416.13 crore in the corresponding quarter last year.
- Sun Pharma plans share buyback starting September 22The offer, for up to 75 lakh shares, will increase the promoter’s shareholding in Sun Pharma marginally to about 55% and cost roughly Rs 67...
- Sun Pharma announces buyback plan at Rs 900 per shareThe buyback price comes at a 16 per cent premium over Rs 752, the closing price of Sun Pharma on Thursday at BSE.
- Sun Pharma merits to be part of core holding of every investor: Dipan Mehta"As compared to international acquisitions done by Indian companies this is a fantastic acquisition for Sun, it is a domestic company."
- Cipla: Sensex berth may trigger buying actionCipla - one of the oldest generic local pharma companies - became part of a select group of stocks which constituted the benchmark Sensex i...
Load More
